A detailed history of Aqr Capital Management LLC transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 98,476 shares of FULC stock, worth $448,065. This represents 0.0% of its overall portfolio holdings.

Number of Shares
98,476
Holding current value
$448,065
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.18 - $9.74 $313,153 - $959,156
98,476 New
98,476 $351,000
Q2 2022

Aug 15, 2022

BUY
$4.2 - $24.0 $58,657 - $335,184
13,966 New
13,966 $68,000
Q1 2022

May 16, 2022

SELL
$9.96 - $23.65 $139,679 - $331,667
-14,024 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$14.0 - $28.44 $196,336 - $398,842
14,024 New
14,024 $248,000

Others Institutions Holding FULC

About Fulcrum Therapeutics, Inc.


  • Ticker FULC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,038,900
  • Market Cap $237M
  • Description
  • Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...
More about FULC
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.